Who Paid My Doc
Christopher Juels
Podiatrist, Foot Surgery Cookeville, TN Doctor of Podiatric Medicine
NPI 1831501824 CMS profile 4520703
105 S Willow Ave, Cookeville, TN 38501
General payments
$207,589
Research payments
$0
Ownership & investment interest
$10,787
Through program year 2025, Christopher Juels of Cookeville, TN is reported in the CMS Open Payments database as having received $207,589 across 306 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $10,787 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $41,231 | 42 | |
| 2024 | General | $35,643 | 18 | |
| 2023 | General | $66,988 | 70 | |
| 2022 | General | $35,218 | 51 | |
| 2021 | General | $18,134 | 53 | |
| 2020 | General | $7,169 | 36 | |
| 2019 | General | $3,206 | 36 | |
| 2022 | Ownership | $5,000 | 1 | |
| 2020 | Ownership | $5,787 | 1 |
Beside peers
- Christopher Juels
- Podiatrist, Foot Surgery median
- Middle half of Podiatrist, Foot Surgery
- National median
In program year 2025, general payments to Christopher Juels were reported at $41,231. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.
Show as a table
| Year | Christopher Juels | Podiatrist, Foot Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,206 | $167 | $67–$484 | $163 |
| 2020 | $7,169 | $114 | $40–$323 | $114 |
| 2021 | $18,134 | $171 | $57–$502 | $132 |
| 2022 | $35,218 | $196 | $66–$556 | $149 |
| 2023 | $66,988 | $187 | $78–$466 | $160 |
| 2024 | $35,643 | $190 | $78–$557 | $164 |
| 2025 | $41,231 | $180 | $70–$569 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
629
Drug cost
$5,288
Branded share of claims
18%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Diclofenac Sodium | Generic | 94 | $2,240 | |
| Meloxicam | Generic | 278 | $743 | |
| Doxycycline Hyclate | Generic | 48 | $691 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 58 | $444 | |
| Methylprednisolone | Generic | 66 | $426 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 41 | $311 | |
| Celecoxib | Generic | 12 | $258 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 14 | $92 | |
| Gabapentin | Generic | 18 | $83 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 118 billing codesPaid by Medicare
$239,977
Medicare patients
452
Services billed
10,449
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 66% | |
| Diabetes | 27% | |
| Ischemic heart disease | 24% | |
| Depression | 24% | |
| Chronic kidney disease | 23% | |
| COPD | 17% | |
| Osteoporosis | 17% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 76 | 7,701 | $755 |
| Injection, methylprednisolone acetate, 80 mg J1040 | Office | 29 | 32 | $176 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
306 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot Surgery in Tennessee
Joseph Creazzo
Podiatrist, Foot Surgery · Morristown, TN
David Velarde
Podiatrist, Foot Surgery · Knoxville, TN
David Franklin
Podiatrist, Foot Surgery · Alcoa, TN
Carol Akerman
Podiatrist, Foot Surgery · Knoxville, TN
Mark Wright
Podiatrist, Foot Surgery · Murfreesboro, TN
James Engblom
Podiatrist, Foot Surgery · Oak Ridge, TN
Related records
Podiatrist, Foot Surgery in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.